New regulations in the Year 2023 for different regulatory bodies around the world
This article will explore new regulations in countries like the United States, Europe, Japan, and Australia.
January 23, 2024
by Muhammad Asim Niazi
Lupin’s Generic Health acquires Southern Cross Pharma in Australia
As a part of the transaction, Generic Health will gain access to over 60 registered products having sales of over AUD 30 million.
August 2, 2021
by expresspharma
Eccogene Announces Completed First-in-human of ECC0509 in Phase 1a Clinical Trial in Australia
Eccogene, Inc., a clinical stage biopharmaceutical company focused on discovery and development of metabolic and immunologic therapeutics, announced the initiation of a Phase 1a clinical trial evaluating ECC0509, an oral inhibitor of ...
July 29, 2021
by prnasia
Italy blocks export of 250,700 AstraZeneca/Oxford Covid-19 vaccines to Australia
The Italian Government has refused to authorise the export of 250,700 doses of AstraZeneca/University of Oxford’s Covid-19 vaccine to Australia.
March 8, 2021
by pharmaceutical-technology
Cipla Gulf expands partnership with Alvotech for commercialisation of biosimilars in Australia and New Zealand
Cipla has announced that it’s subsidiary, Cipla Gulf is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand.
March 2, 2021
by expresspharma
Bionic Vision Technologies Advances Clinical Program With AU$1 million Medical Research Future Fund Grant
Bionic Vision Technologies (BVT) has started work on the next phase of development for its world-leading Australian bionic eye technology thanks to a recent Australian Government grant to refine its vision processing algorithms.
February 22, 2021
by prnasia
Australia approves Pfizer-BioNTech’s Covid-19 vaccine
Australia’s Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer-BioNTech Covid-19 vaccine for use in people aged 16 years and above.
January 26, 2021
by pharmaceutical-technology
Australia brings forward COVID-19 vaccine roll-out to early March
The government plans to complete a mass inoculation programme for its 25 million citizens by the end of this year.
January 7, 2021
by expresspharma
Australia invests AUSD 4 mn for research with India on COVID-19
Apart from new technologies for early detection of COVID-19, the researchers are focusing on the longer-term effects of the virus on the heart and lungs of patients who have recovered.
December 14, 2020
by expresspharma
Australia to acquire 40 million doses of Novavax Covid-19 vaccine
Novavax has signed a non-binding heads of terms document with the Australian Government to supply 40 million doses of its Covid-19 vaccine candidate, NVX-CoV2373.
November 6, 2020
by pharmaceutical-technology
Australia’s star vaccine maker not immune to virus anxiety: Analysis
A promise to supply Australia's 25 million people with a coronavirus vaccine, if one becomes available, has boosted CSL's profile.
October 29, 2020
by expresspharma
Australia enters $1.2bn Covid-19 vaccine supply agreement
The Government of Australia has signed a supply and production agreement valued at A$1.7bn ($1.2bn) to potentially offer a free Covid-19 vaccine to its citizens next year.
September 17, 2020
by pharmaceutical-technology